ETS2, an ETS transcription factor family oncogene, inhibits lung cancer cells’ growth, migration, and invasion by suppressing mesenchymal-epithelial transition (MET) expression (Kabbout et al., 2013). The gene discussed is ETS2; the disease is lung carcinoma.